← Eichor
Condition: Antibody Mediated Rejection Of Lung Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antibody Mediated Rejection Of Lung Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
Phase N/A · 11 location(s) · University of Alberta · NCT02812290A Prospective Randomized Trial of ECP in Subclinical AMR
NA · 7 location(s) · Medical University of Vienna · NCT06112951A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
Phase 1 · 2 location(s) · Washington University School of Medicine · NCT06990711
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.